A putative class action charges Wyeth Inc. with violating antitrust and consumer protection laws by impeding the introduction of a generic version of its antidepressant Effexor XR.
October 24, 2011 at 06:54 PM
1 minute read
A putative class action charges Wyeth Inc. with violating antitrust and consumer protection laws by impeding the introduction of a generic version of its antidepressant Effexor XR.
The suit, filed Oct. 21 on behalf of indirect purchasers of Effexor XR, alleges Wyeth fraudulently obtained three patents on Effexor XR, then sued 13 generic drug makers that sought approval to produce the drug, so it could postpone the rollout of their versions by two years.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
